8:20 am Check-In & Morning Coffee

9:00 am Exploring The Future of Antibody Fragment Drug Conjugates Through Site-Specific Conjugation

• Meddy El Alaoui Chief Scientific Officer, AbTx

9:20 am Chair’s Opening Remarks

Optimizing Site-Specific Conjugations to Control Conjugation Process & Produce Homogeneous DAR

10:00 am Analyzing Next Generation Hydrophilic Click Chemistry for Site-Specific Bioconjugation

• Paul Sauter Director - Chemistry & Bioconjugation, VERAXA Biotech GmbH

10:30 am Roundtable Discussion – Maximizing Site-Specific Conjugations to Enable the Production of High DAR ADCs to Achieve Increased Efficacy

• Alina Chrzastek Conjugation scientist, ADC Therapeutics

11:00 am Morning Break & Speed Networking

Highlighting the Properties & Mechanisms of Payloads to Understand How They Affect Linker & Conjugation Choice

12:00 pm Novel Tools for Payload & Linker Design of Single & Multi-Drug Conjugates With Improved Therapeutic Index

• James Italia Vice President, BrickBio

12:30 pm Generating Site-Specific, Highly Stable Multi-Payload ADCs from Native Antibodies in One Step

• Philipp Spycher Chief Scientific Officer and Co-Founder, Araris

1:00 pm Networking Lunch

2:00 pm Linker & Conjugation Optimization for the ADC With TOP1 Inhibitor Payloads to Prevent DAR Loss & Improve Circulation

• Hyunyong Cho CSO, PinotBio

2:30 pm STRO-004: Discovery and Development of a Novel Tissue Factor ADC Showing Enhanced Efficacy & Safety

• Ravi Singh Sr. Scientist, Sutro Biopharma

3:00 pm Chair’s Closing Remarks

3:10 pm End of Conference